Clinical Trial Update: Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating adding enoxaparin to neoadjuvant chemoradiation for esophageal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Esophageal Neoplasms | Phase 2 | Status: UNKNOWN